Gastrointestinal Drugs Market 2019, Global Industry Analysis, Size, Share, Growth, Trends and Forecast – 2024

WiseGuyReports.com adds “Gastrointestinal Drugs Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024”

PUNE, MARKETERSMEDIA, INDIA, May 23, 2019 /EINPresswire.com/ — Summary

WiseGuyReports.com adds “Gastrointestinal Drugs Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024” reports to its database.

This report provides in depth study of “Gastrointestinal Drugs Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Gastrointestinal Drugs Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn’s disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.

The global Gastrointestinal Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Gastrointestinal Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Gastrointestinal Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3775669-global-gastrointestinal-drugs-market-research-report-2019

The following manufacturers are covered:
AstraZeneca
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria(Tillotts)
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian-Janssen

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug

Segment by Application
Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
Other

At any Query @ https://www.wiseguyreports.com/enquiry/3775669-global-gastrointestinal-drugs-market-research-report-2019

Major Key Points in Table of Content

Executive Summary
1 Gastrointestinal Drugs Market Overview
1.1 Product Overview and Scope of Gastrointestinal Drugs
1.2 Gastrointestinal Drugs Segment by Type
1.2.1 Global Gastrointestinal Drugs Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Prescription Gastrointestinal Drug
1.2.3 OTC Gastrointestinal Drug
1.3 Gastrointestinal Drugs Segment by Application
1.3.1 Gastrointestinal Drugs Consumption Comparison by Application (2014-2025)
1.3.2 Chronic Gastritis
1.3.3 Functional Dyspepsia
1.3.4 Peptic Ulcer
1.3.5 Acute Gastroenteritis
1.3.6 Other
1.4 Global Gastrointestinal Drugs Market by Region
1.4.1 Global Gastrointestinal Drugs Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Gastrointestinal Drugs Market Size
1.5.1 Global Gastrointestinal Drugs Revenue (2014-2025)
1.5.2 Global Gastrointestinal Drugs Production (2014-2025)

2 Global Gastrointestinal Drugs Market Competition by Manufacturers
2.1 Global Gastrointestinal Drugs Production Market Share by Manufacturers (2014-2019)
2.2 Global Gastrointestinal Drugs Revenue Share by Manufacturers (2014-2019)
2.3 Global Gastrointestinal Drugs Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Gastrointestinal Drugs Production Sites, Area Served, Product Types
2.5 Gastrointestinal Drugs Market Competitive Situation and Trends
2.5.1 Gastrointestinal Drugs Market Concentration Rate
2.5.2 Gastrointestinal Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

….

7 Company Profiles and Key Figures in Gastrointestinal Drugs Business
7.1 AstraZeneca
7.1.1 AstraZeneca Gastrointestinal Drugs Production Sites and Area Served
7.1.2 Gastrointestinal Drugs Product Introduction, Application and Specification
7.1.3 AstraZeneca Gastrointestinal Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Sanofi
7.2.1 Sanofi Gastrointestinal Drugs Production Sites and Area Served
7.2.2 Gastrointestinal Drugs Product Introduction, Application and Specification
7.2.3 Sanofi Gastrointestinal Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Bayer
7.3.1 Bayer Gastrointestinal Drugs Production Sites and Area Served
7.3.2 Gastrointestinal Drugs Product Introduction, Application and Specification
7.3.3 Bayer Gastrointestinal Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Pfizer
7.4.1 Pfizer Gastrointestinal Drugs Production Sites and Area Served
7.4.2 Gastrointestinal Drugs Product Introduction, Application and Specification
7.4.3 Pfizer Gastrointestinal Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Gastrointestinal Drugs Production Sites and Area Served
7.5.2 Gastrointestinal Drugs Product Introduction, Application and Specification
7.5.3 GlaxoSmithKline Gastrointestinal Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Teva
7.6.1 Teva Gastrointestinal Drugs Production Sites and Area Served
7.6.2 Gastrointestinal Drugs Product Introduction, Application and Specification
7.6.3 Teva Gastrointestinal Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Zeria(Tillotts)
7.7.1 Zeria(Tillotts) Gastrointestinal Drugs Production Sites and Area Served
7.7.2 Gastrointestinal Drugs Product Introduction, Application and Specification
7.7.3 Zeria(Tillotts) Gastrointestinal Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 Perrigo
7.8.1 Perrigo Gastrointestinal Drugs Production Sites and Area Served
7.8.2 Gastrointestinal Drugs Product Introduction, Application and Specification
7.8.3 Perrigo Gastrointestinal Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 Boehringer Ingelheim
7.9.1 Boehringer Ingelheim Gastrointestinal Drugs Production Sites and Area Served
7.9.2 Gastrointestinal Drugs Product Introduction, Application and Specification
7.9.3 Boehringer Ingelheim Gastrointestinal Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served
7.10 Purdue Pharma
7.10.1 Purdue Pharma Gastrointestinal Drugs Production Sites and Area Served
7.10.2 Gastrointestinal Drugs Product Introduction, Application and Specification
7.10.3 Purdue Pharma Gastrointestinal Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.10.4 Main Business and Markets Served
7.11 C.B. Fleet
7.12 Abbott
7.13 Jiangzhong
7.14 Xian-Janssen

Buy NOW @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3775669

Continued….

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US); Ph: +44 208 133 9349 (UK)

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

Pediatrician Dr. Kenneth Rebong explains Erythema infectiosum (fifth disease)

Pediatrician Dr Kenneth Rebong, San Jose California

Pediatrician Dr Kenneth Rebong, San Jose, California

Kenneth Rebong, MD, doctor in California

Kenneth Rebong, MD, doctor in California

Kenneth Rebong, MD, doctor in California

Kenneth Rebong, MD, doctor in California

Kenneth P. Rebong, MD, doctor in California

Kenneth P. Rebong, MD, doctor in California

Kenneth Rebong, MD, doctor in California

Kenneth Rebong, MD, doctor in California

Among viral infections that children are contracting these days, Erythema infectiosum seems to have become more common. Dr. Kenneth P. Rebong explains.

Kenneth Pomar Rebong, MD (N/A:N/A)

If you believe a child around you is displaying any of the afore-mentioned signs and symptoms, seek medical assistance as soon as possible. In addition, avoid unnecessary physical contact”

— Dr. Kenneth P Rebong, pediatrician

SAN JOSE, CALIFORNIA, UNITED STATES, May 23, 2019 /EINPresswire.com/ — With advancing developments in the field of science and medicine, there are, unfortunately, others things that are further developing as well: viruses and viral infections. It is a global concern currently that viruses are becoming more powerful and harder to be vaccinated against. Among these viruses is the fifth disease or more formally known as Erythema infectiosum.

Dr. Kenneth Rebong has published an overview article on this condition. The complete article will be published on the Blog of Dr. Rebong at https://drkennethrebong.wordpress.com/

The primary targets of fifth diseases are those with weak immune systems and underdeveloped defense mechanisms i.e. children, the elderly, pregnant women, and people who are immunocompromised (HIV/AIDS patients), but mostly children aged between 5-15 years.

Erythema infectiosum, generally referred to as the fifth disease, is caused by a virus called parvovirus B19. This virus is chiefly transmitted by respiratory secretions like saliva, mucus, phlegm etc., but can also be contracted from infected blood. There is currently no vaccine available for the parvovirus B19 for humans.

The symptoms of this infection include mild fevers accompanied by headaches, skin inflammation, rashes, and flu-like symptoms, like a runny nose. Once these symptoms have settled, a distinctive red rash appears on the face making the child seem like they have been slapped on the cheek. A few days later, the rash gradually spreads down to the trunk, arms, and legs. Once the rashes have appeared, the patient is no longer infectious or contagious. The fifth disease infection usually lasts from 1 to 3 weeks for children with no long-lasting effects of the disease. However, in older children and adults, fifth disease, at times, causes swelling of the joints and pain, which lasts for weeks to months and, very seldom, years.

Even though fifth disease does not yet have a vaccine to prevent its proliferation, it can still be treated if contracted. Treatments include fever-reducing medications like antipyretics, itch relieving gels and creams like antipruritics (inhibit itching) and painkillers like aspirin and paracetamol for general body ache. Since the infection is self-limiting, there are no specified therapies prescribed for it. Moreover, because it is a viral infection, antibiotics are not helpful, either.

The fifth disease hardly ever leads to any complications among younger patients. However, in adults and teenagers, it may lead to certain complication. When the disease infects people with weakened immune systems, it momentarily either slows down or stops their body's production of oxygen-binding red blood cells (RBCs), consequently leading to severe anemia and breathing difficulties within the patient which may then be needed to be treated in a hospital.

If you believe a child around you is displaying any of the afore-mentioned signs and symptoms, seek medical assistance as soon as possible. In addition, avoid unnecessary physical contact to prevent contracting an infection, advises Dr. Rebong.

About Dr. Kenneth Pomar Rebong

Dr. Kenneth P. Rebong, a medical doctor in San Jose, California, specializes in Pediatrics and Adolescent Medicine. The scope of his practice is from age 0 to 21. He graduated from FEUNRMF University in Manila, Philippines and completed his residency at Rutgers University in New Brunswick, New Jersey, USA.

Blog: https://drkennethrebong.wordpress.com/
News: https://hype.news/dr-kenneth-pomar-rebong/
https://medicogazette.com/dr-kenneth-pomar-rebong
https://hippocratesguild.com/dr-kenneth-pomar-rebong
https://www.linkedin.com/in/kenneth-pomar-rebong-md-4484a938/

Kenneth Pomar Rebong, MD
Kenneth Pomar Rebong, MD
+ + + + +1 408-729-3232
email us here
Visit us on social media:
LinkedIn

Dr. ERtv: fifth disease – patient education video


Source: EIN Presswire

Non-prescription Drugs Market 2019, Global Industry Analysis, Size, Share, Growth, Trends and Forecast – 2024

WiseGuyReports.com adds “Non-prescription Drugs Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024”

PUNE, MARKETERSMEDIA, INDIA, May 23, 2019 /EINPresswire.com/ — Summary

WiseGuyReports.com adds “Non-prescription Drugs Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024” reports to its database.

This report provides in depth study of “Non-prescription Drugs Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Non-prescription Drugs Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.

The global Non-prescription Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Non-prescription Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Non-prescription Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3775652-global-non-prescription-drugs-market-research-report-2019

The following manufacturers are covered:
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
Allergan
Shire
Boehringer Ingelheim
Takeda

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Brand Drugs
Generic Drug

Segment by Application
Hospital
Clinic
Other

At any Query @ https://www.wiseguyreports.com/enquiry/3775652-global-non-prescription-drugs-market-research-report-2019

Major Key Points in Table of Content

Executive Summary
1 Non-prescription Drugs Market Overview
1.1 Product Overview and Scope of Non-prescription Drugs
1.2 Non-prescription Drugs Segment by Type
1.2.1 Global Non-prescription Drugs Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Brand Drugs
1.2.3 Generic Drug
1.3 Non-prescription Drugs Segment by Application
1.3.1 Non-prescription Drugs Consumption Comparison by Application (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Non-prescription Drugs Market by Region
1.4.1 Global Non-prescription Drugs Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Non-prescription Drugs Market Size
1.5.1 Global Non-prescription Drugs Revenue (2014-2025)
1.5.2 Global Non-prescription Drugs Production (2014-2025)

2 Global Non-prescription Drugs Market Competition by Manufacturers
2.1 Global Non-prescription Drugs Production Market Share by Manufacturers (2014-2019)
2.2 Global Non-prescription Drugs Revenue Share by Manufacturers (2014-2019)
2.3 Global Non-prescription Drugs Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Non-prescription Drugs Production Sites, Area Served, Product Types
2.5 Non-prescription Drugs Market Competitive Situation and Trends
2.5.1 Non-prescription Drugs Market Concentration Rate
2.5.2 Non-prescription Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

….

7 Company Profiles and Key Figures in Non-prescription Drugs Business
7.1 Pfizer
7.1.1 Pfizer Non-prescription Drugs Production Sites and Area Served
7.1.2 Non-prescription Drugs Product Introduction, Application and Specification
7.1.3 Pfizer Non-prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Roche
7.2.1 Roche Non-prescription Drugs Production Sites and Area Served
7.2.2 Non-prescription Drugs Product Introduction, Application and Specification
7.2.3 Roche Non-prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Sanofi
7.3.1 Sanofi Non-prescription Drugs Production Sites and Area Served
7.3.2 Non-prescription Drugs Product Introduction, Application and Specification
7.3.3 Sanofi Non-prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Non-prescription Drugs Production Sites and Area Served
7.4.2 Non-prescription Drugs Product Introduction, Application and Specification
7.4.3 Johnson & Johnson Non-prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Merck & Co. (MSD)
7.5.1 Merck & Co. (MSD) Non-prescription Drugs Production Sites and Area Served
7.5.2 Non-prescription Drugs Product Introduction, Application and Specification
7.5.3 Merck & Co. (MSD) Non-prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Novartis
7.6.1 Novartis Non-prescription Drugs Production Sites and Area Served
7.6.2 Non-prescription Drugs Product Introduction, Application and Specification
7.6.3 Novartis Non-prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 AbbVie
7.7.1 AbbVie Non-prescription Drugs Production Sites and Area Served
7.7.2 Non-prescription Drugs Product Introduction, Application and Specification
7.7.3 AbbVie Non-prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 Gilead Sciences
7.8.1 Gilead Sciences Non-prescription Drugs Production Sites and Area Served
7.8.2 Non-prescription Drugs Product Introduction, Application and Specification
7.8.3 Gilead Sciences Non-prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 GlaxoSmithKline (GSK)
7.9.1 GlaxoSmithKline (GSK) Non-prescription Drugs Production Sites and Area Served
7.9.2 Non-prescription Drugs Product Introduction, Application and Specification
7.9.3 GlaxoSmithKline (GSK) Non-prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served
7.10 Amgen
7.10.1 Amgen Non-prescription Drugs Production Sites and Area Served
7.10.2 Non-prescription Drugs Product Introduction, Application and Specification
7.10.3 Amgen Non-prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.10.4 Main Business and Markets Served
7.11 AstraZeneca
7.12 Bristol-Myers Squibb
7.13 Eli Lilly
7.14 Teva
7.15 Bayer
7.16 Novo Nordisk
7.17 Allergan
7.18 Shire
7.19 Boehringer Ingelheim
7.20 Takeda

Buy NOW @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3775652

Continued….

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US); Ph: +44 208 133 9349 (UK)

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

Global IoT Analytics Market Report 2019 by Technology, Future trends, Top Key Players, Size and Forecast to 2025

A new market study, titled “Global IoT Analytics Market Size, Status and Forecast 2019-2025”, has been featured on WiseGuyReports.

PUNE, MAHARASTRA, INDIA, May 23, 2019 /EINPresswire.com/ — IoT Analytics Market

In 2018, the global IoT Analytics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global IoT Analytics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the IoT Analytics development in United States, Europe and China.

The key players covered in this study 
IBM 
MICROSOFT 
ORACLE 
SAP 
CISCO SYSTEMS 
DELL TECHNOLOGIES 
GOOGLE 
HEWLETT PACKARD ENTERPRISE 
PTC 
HITACHI 
TERADATA 
GREENWAVE SYSTEMS 
MNUBO

Request Free Sample Report at https://www.wiseguyreports.com/sample-request/4059640-global-iot-analytics-market-size-status-and-forecast-2019-2025

Market segment by Type, the product can be split into 
Small And Medium-Sized Enterprises 
Big Companies

Market segment by Application, split into 
Government, Defense 
Medical Science, Life Science 
Energy, Utilities 
Communication, IT 
Transportation And Logistics 
Other

Market segment by Regions/Countries, this report covers 
United States 
Europe 
China 
Japan 
Southeast Asia 
India 
Central & South America

The study objectives of this report are: 
To analyze global IoT Analytics status, future forecast, growth opportunity, key market and key players. 
To present the IoT Analytics development in United States, Europe and China. 
To strategically profile the key players and comprehensively analyze their development plan and strategies. 
To define, describe and forecast the market by product type, market and key regions.

Table of Content:
1 Report Overview 
2 Global Growth Trends 
3 Market Share by Key Players 
4 Breakdown Data by Type and Application 
5 United States 
6 Europe 
7 China 
8 Japan 
9 Southeast Asia 
10 India 
11 Central & South America 
12 International Players Profiles 
13 Market Forecast 2019-2025 
14 Analyst's Viewpoints/Conclusions
15 Appendix 

View Detailed Report at https://www.wiseguyreports.com/reports/4059640-global-iot-analytics-market-size-status-and-forecast-2019-2025

About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.   

Contact Us:
NORAH TRENT                                                      
sales@wiseguyreports.com       
Ph: +1-646-845-9349 (US)                          
Ph: +44 208 133 9349 (UK)      

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

Global Lawful Interception Market Report 2019-2025 by Technology, Future Trends, Opportunities, Top Vendors and more…

A new market study, titled “Global Lawful Interception Market Size, Status and Forecast 2019-2025”, has been featured on WiseGuyReports.

PUNE, MAHARASTRA, INDIA, May 23, 2019 /EINPresswire.com/ — Lawful Interception Market

Lawful interception is an official access to private communications, such as phone or email, that is legally supported. The major driving force for the LI market is the sophisticated communication channels and the advancement in network technologies. 

This report focuses on the global Lawful Interception status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Lawful Interception development in United States, Europe and China.

The key players covered in this study 
Aqsacom 
Cisco Systems 
Incognito Software 
Net Optics 
Netscout 
Siemens 
Utimaco 
Verint 
ZTE

Request Free Sample Report at https://www.wiseguyreports.com/sample-request/4059803-global-lawful-interception-market-size-status-and-forecast-2019-2025

Market segment by Type, the product can be split into 
Wimax 
DSL 
PSTN 
ISDN 
CDMA 
GSM 
GPRS

Market segment by Application, split into 
Government And Public Institutions 
Law Enforcement Agencies 
Small And Medium-Sized Enterprises

Market segment by Regions/Countries, this report covers 
United States 
Europe 
China 
Japan 
Southeast Asia 
India 
Central & South America

The study objectives of this report are: 
To analyze global Lawful Interception status, future forecast, growth opportunity, key market and key players. 
To present the Lawful Interception development in United States, Europe and China. 
To strategically profile the key players and comprehensively analyze their development plan and strategies. 
To define, describe and forecast the market by product type, market and key regions.

Table of Content:
1 Report Overview 
2 Global Growth Trends 
3 Market Share by Key Players 
4 Breakdown Data by Type and Application 
5 United States 
6 Europe 
7 China 
8 Japan 
9 Southeast Asia 
10 India 
11 Central & South America 
12 International Players Profiles 
13 Market Forecast 2019-2025 
14 Analyst's Viewpoints/Conclusions
15 Appendix 

View Detailed Report at https://www.wiseguyreports.com/reports/4059803-global-lawful-interception-market-size-status-and-forecast-2019-2025

About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.   

Contact Us:
NORAH TRENT                                                      
sales@wiseguyreports.com       
Ph: +1-646-845-9349 (US)                          
Ph: +44 208 133 9349 (UK)      

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

Global Chiropractic Software Market Report 2019-2025 by Technology, Future Trends, Top Key Players and more…

A new market study, titled “Global Chiropractic Software Market Size, Status and Forecast 2019-2025”, has been featured on WiseGuyReports.

PUNE, MAHARASTRA, INDIA, May 23, 2019 /EINPresswire.com/ — Chiropractic Software Market

Chiropractic software is an application that automates every major administrative process in a chiropractic practice. Chiropractic practices are increasingly adopting chiropractic software as they deal with a large volume of patient data that includes both clinical and administrative data. 

This report focuses on the global Chiropractic Software status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Chiropractic Software development in United States, Europe and China.

The key players covered in this study 
AdvancedMD 
MacPractice 
Nuesoft Technologies 
OfficeAlly 
Practice Fusion 
Addison Health Systems 
Atlas Chiropractic System 
ChiroPulse 
ChiroSpring 
ChiroTouch 
com 
CloudChiro 
CollaborateMD 
CompuGroup Medical 
drchrono 
E-Z BIS 
Forte Holdings 
Genesis Chiropractic Software 
InPhase Technologies 
iSALUS Healthcare 
Life Systems Software

Request Free Sample Report at https://www.wiseguyreports.com/sample-request/4059546-global-chiropractic-software-market-size-status-and-forecast-2019-2025

Market segment by Type, the product can be split into 
Cloud-based Chiropractic Software 
Web-based Chiropractic Software

Market segment by Application, split into 
Hospitals 
Research Institutes 
Others

Market segment by Regions/Countries, this report covers 
United States 
Europe 
China 
Japan 
Southeast Asia 
India 
Central & South America

The study objectives of this report are: 
To analyze global Chiropractic Software status, future forecast, growth opportunity, key market and key players. 
To present the Chiropractic Software development in United States, Europe and China. 
To strategically profile the key players and comprehensively analyze their development plan and strategies. 
To define, describe and forecast the market by product type, market and key regions.

Table of Content:
1 Report Overview 
2 Global Growth Trends 
3 Market Share by Key Players 
4 Breakdown Data by Type and Application 
5 United States 
6 Europe 
7 China 
8 Japan 
9 Southeast Asia 
10 India 
11 Central & South America 
12 International Players Profiles 
13 Market Forecast 2019-2025 
14 Analyst's Viewpoints/Conclusions
15 Appendix 

View Detailed Report at https://www.wiseguyreports.com/reports/4059546-global-chiropractic-software-market-size-status-and-forecast-2019-2025

About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.   

Contact Us:
NORAH TRENT                                                      
sales@wiseguyreports.com       
Ph: +1-646-845-9349 (US)                          
Ph: +44 208 133 9349 (UK)      

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

Estudiando la luna durante el eclipse solar total

Sol Luna tierra postulando para Eclipse total

Sol Luna tierra postulando para Eclipse total

Cuentas de Baily-Eclipse solar

Cuentas de Baily-Eclipse solar

eclipse solar

eclipse solar

La emoción sobre del eclipse solar total gira principalmente alrededor del sol. Sin embargo, la Luna también juega un papel importante durante este evento.

El total de eclipses solares ocurren cuando la luna nueva se produce entre el sol y la tierra y arroja la parte más oscura de su sombra, la Umbra, en la tierra. Un eclipse solar completo,…”

— timeanddate.com

BUENO AIRES, ARGENTINA, May 23, 2019 /EINPresswire.com/ — Ver el eclipse total es sobre el Sol, la Luna y la Tierra. Unicamente es posible cuando la Luna y el Sol están en una alineación única en el cielo.

El eclipse total implica que la Luna oculte completamente la cara del Sol durante varios minutos. Esto ofrece a los espectadores e investigadores la oportunidad de ver el halo blanco de la corona o la atmósfera exterior. El Sol y la Luna están casi perfectamente alineados durante el eclipse total, y el tamaño aparente del Sol coincide con el tamaño aparente de la Luna.

Un eclipse total de sol es un evento que ocurre una vez cada 18 meses en diferentes lugares del planeta. Sin embargo, es mucho menos frecuente que el eclipse se produzca en el mismo lugar.

El 2 de julio de 2019, el eclipse solar total y parcial será visible en Argentina. El camino de la totalidad recorrerá las provincias de Buenos Aires, La Rioja, Córdoba, Santa Fe, San Luis y San Juan. Las personas en San Juan, Río Cuarto, Dolores, Villa Dolores, Merlo y Lujan podrán experimentar el eclipse total de sol.

A lo largo del camino de la totalidad, la sombra interior oscura de la Luna, conocida como la umbra, viajará a una velocidad de aproximadamente 3,000 millas por hora. La umbra aparece en los mapas de eclipse como un óvalo oscuro o un círculo a través del paisaje. Sin embargo, las visualizaciones más recientes lo revelan como un polígono irregular con bordes curvos, cuya forma cambia a medida que el umbra se mueve a través de la ruta de la totalidad.

Las visualizaciones recientes son más precisas al representar la umbra porque explican el impacto de la elevación en diferentes lugares del planeta y la forma en que la luz del Sol se filtra a través de los valles a lo largo del borde de la Luna.

Este nivel de detalle se puede lograr combinando el mapeo 3D de la superficie de la Luna, realizado por el Lunar Reconnaissance Orbiter de la NASA, y la información sobre la elevación de la Tierra obtenida de varios conjuntos de datos.

El mapeo del terreno de la Luna realizado por el LRO permite predecir la aparición de las Bolas de Baily, los destellos de luz brillantes o el efecto de anillo de diamante. Estos aparecen a lo largo de los bordes del disco justo antes y justo después de la totalidad y son el resultado de la luz solar que se filtra a través de los valles a lo largo del borde de la Luna.

La Luna está retrocediendo lentamente de la Tierra, y se está alejando 4 centímetros más que el año anterior. Una vez que la Luna alcance una distancia suficiente, su tamaño aparente no será suficiente para cubrir completamente al Sol. Como resultado, en un futuro lejano, no habrá un evento como el eclipse total de sol.

Se cree que la frecuencia y el número de eclipses solares totales continuarán disminuyendo. Por última vez, el eclipse solar ocurrirá en unos 600 millones de años a partir de ahora.

Prepárate para el Eclipse solar total con la protección adecuada para tus ojos. Utilice siempre gafas solares certificadas con ISO.

Tommy Hintz
Educacion Eclipse
+54 9 (11) 5747-9694
email us here

2 de julio 2019 total solar eclipse Argentina gafas de Sudamérica


Source: EIN Presswire

New Book Reconciles Creation and Evolution

Dr. Niamh Middleton

Dr. Niamh Middleton

Homo Lapsus

HOMO LAPSUS: Sin, Evolution, and the God Who Is Love

Written by Atheist Turned Theology Professor Dr. Niamh Middleton, HOMO LAPSUS Demonstrates the Link Between Evolutionary Biology and the Origin of Life.

The key to resolving the apparent conflicts between religion and science—and especially between evolutionary biology and Christianity—lies in confronting the implications of evolution for morality.”

— Dr. Niamh Middleton

CHICAGO, IL, USA, May 23, 2019 /EINPresswire.com/ — For decades, Christians have discussed how evolution and intelligent design may not be mutually exclusive, although divisions on the topic remain. Related to this issue is the relationship between the theory of evolution and the origin of evil.

In "HOMO LAPSUS: Sin, Evolution, and the God Who Is Love," author and theology professor Dr. Niamh Middleton explores the link between evolutionary biology and Christianity and the origins of evil. Through her study of biology and theology, Middleton suggests that evolutionary biology provides evidence for Christian teachings on the issues of the origin of humanity, the origin of evil, and the existence of a benevolent Deity.

As Middleton researched and wrote HOMO LAPSUS, she became increasingly aware of the divisions among Christians on the topic of human origins because of the scientific doctrine of evolution. She explains, “The key to resolving the apparent conflicts between religion and science—and especially between evolutionary biology and Christianity—lies in confronting the implications of evolution for morality. Only when this has been achieved will it be possible to achieve harmony between the two disciplines.”

Dr. Middleton’s life and studies have made her well versed in multiple worldviews and differing doctrines. A native of Dublin, Ireland, Middleton was an atheist when she married a man who was, at the time, considering becoming a Roman Catholic priest. Over 10 years later, Niamh became a Christian when she was required to teach religion for her job as a primary school teacher. The more she studied, the more her love for theology blossomed, and after a personal crisis, she realized the true comfort and hope she had in Christ. Soon after, she earned her PhD in theology from St. Patrick’s Pontifical University, Maynooth in 2003. She now lectures on theology at Dublin City University.

HOMO LAPSUS: Sin, Evolution, and the God Who Is Love, is published by Deep River Books.

About the Author:
Dr. Niamh Middleton is a former primary school teacher who now lectures about theology at Dublin City University. When she met her teenage sweetheart and future husband Gerry, she was an atheist and he was considering becoming a Roman Catholic priest. Despite their disagreement on the subject of religion, he changed his mind and they married, becoming the parents of two daughters. Niamh remained an atheist for over a decade after her marriage until a challenging life event caused her to explore faith and draw comfort from it. She became a born-again Christian and in 1994 began a study of theology, which culminated with being awarded a Ph.D. in 2003. She lives in the seaside suburb of Clontarf, Dublin, where she is involved in an ecumenical Bible study group. She enjoys reading, writing, music, and traveling.

# # #

Lori Heiselman
FrontGate PR
714-553-5181
email us here


Source: EIN Presswire

Next-Generation Firewall Market 2019 Global Share, Supply, Demand, Segmentation and Forecast to 2025

Wise.Guy12

Wise.Guy.

Wiseguyreports.Com Adds “Next-Generation Firewall 2019-2025 Global Market Survey Industry Key Players" To Its Research Database

PUNE, MAHARASTRA, INDIA, May 23, 2019 /EINPresswire.com/ — Next-Generation Firewall Market 2019-2025

Description: –

A next-generation firewall (NGFW) is a part of the third generation of firewall technology, combining a traditional firewall with other network device filtering functionalities, such as an application firewall using in-line deep packet inspection (DPI), an intrusion prevention system (IPS). Other techniques might also be employed, such as TLS/SSL encrypted traffic inspection, website filtering, QoS/bandwidth management, antivirus inspection and third-party identity management integration.

Scope of the Report:

NGFWs include the typical functions of traditional firewalls such as packet filtering, network- and port-address translation (NAT), stateful inspection, and virtual private network(VPN) support. The goal of next-generation firewalls is to include more layers of the OSI model, improving filtering of network traffic that is dependent on the packet contents. NGFWs perform deeper inspection compared to stateful inspection performed by the first- and second-generation firewalls. NGFWs use a more thorough inspection style, checking packet payloads and matching signatures for harmful activities such as exploitable attacks and malware.

Free Sample Report @ https://www.wiseguyreports.com/sample-request/4052167-global-next-generation-firewall-market-size-status-and-forecast-2019-2025

The major manufacturers covered in this report

Cisco Systems
Fortinet
Barracuda Networks
Juniper Networks
Palo Alto Networks
Forcepoint
Zscaler
Watchguard Technologies
Sophos Group
Check Point Software Technologies

Market analysis by product type
Firewall
Identity-Based Security
Unified Threat Management
Network Security

Market analysis by market
BFSI
Telecommunication And IT
Healthcare
Retail And Wholesale
Manufacturing
Government

Market analysis by Region
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Next-Generation Firewall status, future forecast, growth opportunity, key market and key players.
To present the Next-Generation Firewall development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

For Detailed Report Visit @ https://www.wiseguyreports.com/reports/4052167-global-next-generation-firewall-market-size-status-and-forecast-2019-2025

Major Key Points in Table of Content:

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.2 Firewall
1.4.3 Identity-Based Security
1.4.4 Unified Threat Management
1.4.5 Network Security
1.5 Market by Application
1.5.1 Global Next-Generation Firewall Market Share by Application (2018-2025)
1.5.2 BFSI
1.5.3 Telecommunication And IT
1.5.4 Healthcare
1.5.5 Retail And Wholesale
1.5.6 Manufacturing
1.5.7 Government
1.6 Study Objectives
1.7 Years Considered

…………….

9 International Players Profiles
9.1 Cisco Systems
9.1.1 Cisco Systems Company Details
9.1.2 Company Description and Business Overview
9.1.3 Next-Generation Firewall Introduction
9.1.4 Cisco Systems Revenue in Next-Generation Firewall Business (2018-2019)
9.1.5 Cisco Systems Recent Development
9.2 Fortinet
9.2.1 Fortinet Company Details
9.2.2 Company Description and Business Overview
9.2.3 Next-Generation Firewall Introduction
9.2.4 Fortinet Revenue in Next-Generation Firewall Business (2018-2019)
9.2.5 Fortinet Recent Development
9.3 Barracuda Networks
9.3.1 Barracuda Networks Company Details
9.3.2 Company Description and Business Overview
9.3.3 Next-Generation Firewall Introduction
9.3.4 Barracuda Networks Revenue in Next-Generation Firewall Business (2018-2019)
9.3.5 Barracuda Networks Recent Development
9.4 Juniper Networks
9.4.1 Juniper Networks Company Details
9.4.2 Company Description and Business Overview
9.4.3 Next-Generation Firewall Introduction
9.4.4 Juniper Networks Revenue in Next-Generation Firewall Business (2018-2019)
9.4.5 Juniper Networks Recent Development
9.5 Palo Alto Networks
9.5.1 Palo Alto Networks Company Details
9.5.2 Company Description and Business Overview
9.5.3 Next-Generation Firewall Introduction
9.5.4 Palo Alto Networks Revenue in Next-Generation Firewall Business (2017-2018)
9.5.5 Palo Alto Networks Recent Development
9.6 Forcepoint
9.6.1 Forcepoint Company Details
9.6.2 Company Description and Business Overview
9.6.3 Next-Generation Firewall Introduction
9.6.4 Forcepoint Revenue in Next-Generation Firewall Business (2017-2018)
9.6.5 Forcepoint Recent Development
9.7 Zscaler
9.7.1 Zscaler Company Details
9.7.2 Company Description and Business Overview
9.7.3 Next-Generation Firewall Introduction
9.7.4 Zscaler Revenue in Next-Generation Firewall Business (2018-2019)
9.7.5 Zscaler Recent Development

Continued……

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

Eliseo Delgado Explains How Recent Advances in Artificial Intelligence Affect Modern Workers

Eliseo Delgado

RIVERSIDE, CALIFORNIA, USA, May 22, 2019 /EINPresswire.com/ — Computer engineer Eliseo Delgado has spent the past ten years reviewing consumer products and reporting on the latest advances in technology. He shares his savviness and insight with readers on the latest advances in artificial intelligence and how they affect the modern workplace.

A graduate from the New York University Tandon School of Engineering, computer engineer Eliseo Delgado has worked with a range of tech advances in his career and is an authoritative voice on topics like artificial intelligence, cryptocurrency, and the Internet of Things (IoT). Below, he helps readers understand some of the recent advances in artificial intelligence and machine learning and how it’s affecting contemporary employees.

“We’ve worked alongside machines since the Industrial Revolution, but only in the last couple of decades have we introduced machine learning to the workplace,” says Eliseo Delgado. “This new element ultimately helps researchers, engineers, clinicians and other professionals perform work more efficiently and enhance their output.”

Artificial intelligence allows professionals to do things like process massive amounts of data quickly and expedite services, which in turn enables them to provide answers or assemble information much more quickly. While engineers aren’t giving machines the total cognitive representation of the human mind, they allow them to think and act like humans under certain conditions, especially by using tools and problem-solving skills to improve processes.

“Through artificial intelligence, we can teach machines to perform a range of cognitive tasks as well as task advanced machinery with increasingly difficult manual tasks,” says Eliseo Delgado. “These enhancements will help propel a lot of careers to be more productive, but it will also have adverse effects on certain positions or job fields.”

Increased productivity and lowered costs thanks to advances in artificial intelligence will benefit society overall but may impact individual workers or specific fields in negative ways. Industries like commercial truck driving are likely to replace human workers with AI self-driving vehicles. Many factory positions have already seen their workers replaced by more efficient machines that can provide seemingly unlimited output.

However, machine learning has improved other industries such as education and medicine in dramatic ways. In education, artificial intelligence can be used to improve curriculum, automate basic activities like grading, and provide students with support and tutoring. In medicine, improved algorithms and artificial intelligence can help diagnose diseases and conditions more accurately as well as assist during procedures, freeing up time for doctors and surgeons.

“AI has the potential to replace certain roles, but it can also assist those with specialized positions who may not have other human candidates in the field to turn to,” says Eliseo Delgado.

Artificial intelligence empowers the workplace in new ways and helps accomplish feats that would otherwise be unattainable, and it’s proving to be a necessary tool for progress.

Caroline Hunter
Web Presence, LLC
+1 7865519491
email us here


Source: EIN Presswire